Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8374)
All Articles published online
|
Publishing Process of This Article
|
Jan 18, 2017 (publication date) through Nov 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Samonakis DN, Kouroumalis EA. Systemic treatment for hepatocellular carcinoma: Still unmet expectations. World J Hepatol 2017; 9(2): 80-90 [PMID: 28144389 DOI: 10.4254/wjh.v9.i2.80] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v9/i2/80.htm |
| Number | Citing Articles |
| 1 |
Zhong-Liang Su, Chien-Wei Su, Yi-Luen Huang, Wan-Yu Yang, Bonifasius Putera Sampurna, Toru Ouchi, Kuan-Lin Lee, Chen-Sheng Wu, Horng-Dar Wang, Chiou-Hwa Yuh. A Novel AURKA Mutant-Induced Early-Onset Severe Hepatocarcinogenesis Greater than Wild-Type via Activating Different Pathways in Zebrafish. Cancers 2019; 11(7): 927 doi: 10.3390/cancers11070927
|
| 2 |
Zhen Wang, Yan-Jiang Han, Shun Huang, Meng Wang, Wen-Lan Zhou, Hong-Sheng Li, Quan-Shi Wang, Hu-Bing Wu. Imaging the expression of glypican-3 in hepatocellular carcinoma by PET. Amino Acids 2018; 50(2): 309 doi: 10.1007/s00726-017-2517-z
|
| 3 |
Mamdouh M Ali, Ibrahim H Borai, Hala M Ghanem, Abeer H Abdel-Halim, Fatma M Mousa. The prophylactic and therapeutic effects of Momordica charantia methanol extract through controlling different hallmarks of the hepatocarcinogenesis. Biomedicine & Pharmacotherapy 2018; 98: 491 doi: 10.1016/j.biopha.2017.12.096
|
| 4 |
Wan-Yu Yang, Pei-Shu Rao, Yong-Chun Luo, Hua-Kuo Lin, Sing-Han Huang, Jinn-Moon Yang, Chiou-Hwa Yuh. Omics-based Investigation of Diet-induced Obesity Synergized with HBx, Src, and p53 Mutation Accelerating Hepatocarcinogenesis in Zebrafish Model. Cancers 2019; 11(12): 1899 doi: 10.3390/cancers11121899
|
| 5 |
Preedia Babu Ezhuthupurakkal, Subastri Ariraman, Suyavaran Arumugam, Nithyananthan Subramaniyan, Suresh Kumar Muthuvel, Premkumar Kumpati, Bharathidasan Rajamani, Thirunavukkarasu Chinnasamy. Anticancer potential of ZnO nanoparticle-ferulic acid conjugate on Huh-7 and HepG2 cells and diethyl nitrosamine induced hepatocellular cancer on Wistar albino rat. Nanomedicine: Nanotechnology, Biology and Medicine 2018; 14(2): 415 doi: 10.1016/j.nano.2017.11.003
|
| 6 |
Zhou-wei Xu, Shang-xue Yan, Hua-xun Wu, Ying Zhang, Wei Wei. Angiotensin II and tumor necrosis factor-α stimulate the growth, migration and invasion of BEL-7402 cells via down-regulation of GRK2 expression. Digestive and Liver Disease 2019; 51(2): 263 doi: 10.1016/j.dld.2018.06.007
|
| 7 |
Yan Chen, Jiongshan Zhang, Mengting Liu, Zengcheng Zou, Fenglin Wang, Hao Hu, Baoguo Sun, Shijun Zhang. Risk of Developing Hepatocellular Carcinoma following Depressive Disorder Based on the Expression Level of Oatp2a1 and Oatp2b1. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/3617129
|
| 8 |
Hanan Omar, Samaa Taha, Wafaa Hassan, Hamdy Omar. Occult hepatitis B infection: a hidden factor of poor response to intervention treatment of hepatocellular carcinoma in chronic hepatitis C patients. Comparative Clinical Pathology 2018; 27(5): 1273 doi: 10.1007/s00580-018-2735-0
|
| 9 |
Keita Fukuyama, Masataka Asagiri, Masahiro Sugimoto, Hiraki Tsushima, Satoru Seo, Kojiro Taura, Shinji Uemoto, Keiko Iwaisako, Matias A Avila. Gene expression profiles of liver cancer cell lines reveal two hepatocyte-like and fibroblast-like clusters. PLOS ONE 2021; 16(2): e0245939 doi: 10.1371/journal.pone.0245939
|
| 10 |
I. Walter, U. Schulz, M. Vogelhuber, K. Wiedmann, E. Endlicher, F. Klebl, R. Andreesen, W. Herr, L. Ghibelli, C. Hackl, R. Wiest, A. Reichle. Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial. Medical Oncology 2017; 34(12) doi: 10.1007/s12032-017-1040-0
|
| 11 |
María Paula Ceballos, Juan Pablo Rigalli, Lucila Inés Ceré, Mariana Semeniuk, Viviana Alicia Catania, María Laura Ruiz. ABC Transporters: Regulation and Association with Multidrug Resistance in Hepatocellular Carcinoma and Colorectal Carcinoma. Current Medicinal Chemistry 2019; 26(7): 1224 doi: 10.2174/0929867325666180105103637
|
| 12 |
BaoChun Wang, Jian Xu, HaiYang Wang, ShunWu Chang, Ning Liu. Effect and Mechanism of Sophoridine to suppress Hepatocellular carcinoma in vitro and vivo. Biomedicine & Pharmacotherapy 2017; 95: 324 doi: 10.1016/j.biopha.2017.08.029
|
| 13 |
Rasha R. Radwan, Hussein E. Ali. Radiation-synthesis of chitosan/poly (acrylic acid) nanogel for improving the antitumor potential of rutin in hepatocellular carcinoma. Drug Delivery and Translational Research 2021; 11(1): 261 doi: 10.1007/s13346-020-00792-7
|
| 14 |
Nithyananthan Subramaniyam, Suyavaran Arumugam, Preedia Babu Ezthupurakkal, Subastri Ariraman, Indrani Biswas, Suresh Kumar Muthuvel, Aristatile Balakrishnan, Ghedeir M. Alshammari, Thirunavukkarasu Chinnasamy. Unveiling anticancer potential of glibenclamide: Its synergistic cytotoxicity with doxorubicin on cancer cells. Journal of Pharmaceutical and Biomedical Analysis 2018; 154: 294 doi: 10.1016/j.jpba.2018.03.025
|
| 15 |
Linh Nguyen, Sunny Chapel, Benjamin Duy Tran, Steven Lacy. Cabozantinib exposure–response analyses of efficacy and safety in patients with advanced hepatocellular carcinoma. Journal of Pharmacokinetics and Pharmacodynamics 2019; 46(6): 577 doi: 10.1007/s10928-019-09659-y
|
| 16 |
Özge Eroğlu Gülümsek, Esma Erciyas Baykal, Cansu Küçükpolat, Emel Önal, Pelin Balcik-Ercin, Tamer Yagci, Vefa Ahsen, Ayşe Gül Gürek. Bis[N,N′-bis(anilino)glioximato]platinum(II) complex: synthesis, characterization and biological activity. Journal of Coordination Chemistry 2022; 75(1-2): 197 doi: 10.1080/00958972.2022.2028779
|
| 17 |
Kaustav Dutta Chowdhury, Avik Sarkar, Sujan Chatterjee, Debajyoti Patra, Dipanwita Sengupta, Soumi Banerjee, Pratip Chakraborty, Gobinda Chandra Sadhukhan. Cathepsin B mediated scramblase activation triggers cytotoxicity and cell cycle arrest by andrographolide to overcome cellular resistance in cisplatin resistant human hepatocellular carcinoma HepG2 cells. Environmental Toxicology and Pharmacology 2019; 68: 120 doi: 10.1016/j.etap.2019.03.003
|
| 18 |
Ya Li, Qiuju Han, Huajun Zhao, Quanjuan Guo, Jian Zhang. Napabucasin Reduces Cancer Stem Cell Characteristics in Hepatocellular Carcinoma. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.597520
|
| 19 |
Elias Kouroumalis, Ioannis Tsomidis, Argryro Voumvouraki. Is There a Place for Somatostatin Analogues for the Systemic Treatment of Hepatocellular Carcinoma in the Immunotherapy Era?. Livers 2022; 2(4): 315 doi: 10.3390/livers2040024
|
| 20 |
Shukui Qin, Richard S Finn, Masatoshi Kudo, Tim Meyer, Arndt Vogel, Michel Ducreux, Teresa Mercade Macarulla, Gianluca Tomasello, Frederic Boisserie, Jeannie Hou, Xin Li, James Song, Andrew X Zhu. RATIONALE 301 Study: Tislelizumab Versus Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma. Future Oncology 2019; 15(16): 1811 doi: 10.2217/fon-2019-0097
|
| 21 |
Aakash Desai, Sonia Sandhu, Jin-Ping Lai, Dalbir Singh Sandhu. Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review. World Journal of Hepatology 2019; 11(1): 1-18 doi: 10.4254/wjh.v11.i1.1
|